AVLN — Avalyn Pharma Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Avalyn Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 24 | 52.3 |
| Net Total Receivables | 0.591 | 0.537 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 114 | 144 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 0.094 | 2.32 |
| Other Long Term Assets | ||
| Total Assets | 125 | 149 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 8.74 | 14.1 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 8.74 | 15.3 |
| Redeemable Preferred Stock | ||
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 116 | 134 |
| Total Liabilities & Shareholders' Equity | 125 | 149 |
| Total Common Shares Outstanding |